USA flag logo/image

An Official Website of the United States Government

DESIGN OF MODIFIED PROTEIN C BY MOLECULAR MODELING

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
13946
Program Year/Program:
1990 / SBIR
Agency Tracking Number:
13946
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Integrated Genetics Inc
1 Mountain Rd Framingham, MA 01701
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1990
Title: DESIGN OF MODIFIED PROTEIN C BY MOLECULAR MODELING
Agency: HHS
Contract: N/A
Award Amount: $50,000.00
 

Abstract:

THE COAGULATION CASCADE CONSISTS OF A NUMBER OF MULTIDOMAIN SERINE PROTEASES AND PROTEIN COFACTORS. AMONG THESE ARE FACTORS IX, X, AND PROTHROMBIN. PROTEIN C DOWNREGULATES THE INTRINSIC COAGULATION PATHWAY BY INACTIVATING FACTORS VAAND VIIIA. FACTORS IX, X, AND PROTEIN C ARE HIGHLY HOMOLOGOUS PROTEINS. EACH CONTAINS TWO EGF-HOMOLOGOUS DOMAINS AND A N-TERMINAL DOMAIN BEARING MULTIPLE -CARBOXYGLUTAMIC ACID RESIDUES, THE SO-CALLED GLA DOMAIN. COMPETITIVE BINDING EXPERIMENTS HAVE ESTABLISHED THAT FACTORS IX AND X BIND TO RECEPTORS ON ACTIVATED ENDOTHELIAL CELLS THROUGH INTERACTIONS OF THE EGF AND GLA DOMAINS, A PHYSIOLOGICAL MECHANISM FOR DIRECTING COAGULATION TO REGIONS OF DAMAGED ENDOTHELIUM. THE OBJECTIVE IS TO IMPROVE RECOMBINANT PROTEIN C FOR USE ASA SAFE ANTICOAGULANT/ANTITHROMBOTIC AGENT FOR SUPPRESSION OF CLOTTING IN A NUMBER OF VENOUS THROMBOTIC CONDITIONS. SPECIFICALLY, A PROTEIN C VARIANT WITH A HIGH BINDING AFFINITY FOR DAMAGED ENDOTHELIUM WILL BE DESIGNED. THE EGF-HOMOLOGOUS DOMAINS OF PROTEIN C HAVE BEEN IDENTIFIED AS REGIONS THAT CAN BE ENGINEERED TO CONFER BINDING AFFINITYFOR THE FACTOR IX ENDOTHELIAL CELL RECEPTOR. IN PHASE I, MOLECULAR MODELING WILL BE USED TO IDENTIFY RESIDUES IN THE EGF-HOMOLOGOUS DOMAINS OF PROTEIN C THAT CAN BE ALTERED TO MORE CLOSELY MIMIC THE COMPARABLE DOMAIN OF FACTOR IX. IN PHASE II, VARIANTS OF PROTEIN C WITH THESE MUTATIONS WILL BEGENERATED AND THEIR SPECIFIC ACTIONS WITH FACTORS IX, VA AND VIIIA WILL BE DETERMINED.

Principal Investigator:

Parthasarathy Manavalan
5088728400

Business Contact:

Small Business Information at Submission:

Integrated Genetics Inc
1 Mountain Rd Framingham, MA 01701

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No